Tumor Ablation Market by Mode of Treatment (Percutaneous, Surgical, Laparoscopic), Technology (Cryoablation, Radiofrequency, Microwave, Laser, IRE, Ultrasound), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) – Global Forecast 2021

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: March 23, 2020
Clear
SKU: GMS-3050 Category:

The Global Tumor Ablation Market is expected to grow at a CAGR of 12.78% during the forecast period 2020-2025. Technological advances in tumor ablation combined with increased surgical safety profile, increased consumer demand for minimally invasive tumor ablation techniques, increased cancer prevalence across the globe, and an growing amount of public-private partnerships & funding to support ongoing tumor ablation research are driving consumer development.

Tumor Ablation Market by Mode of Treatment (Percutaneous, Surgical, Laparoscopic), Technology (Cryoablation, Radiofrequency, Microwave, Laser, IRE, Ultrasound), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021 1

Tumor Ablation Market by Mode of Treatment (Percutaneous, Surgical, Laparoscopic), Technology (Cryoablation, Radiofrequency, Microwave, Laser, IRE, Ultrasound), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021 2

Tumor Ablation Market by Mode of Treatment (Percutaneous, Surgical, Laparoscopic), Technology (Cryoablation, Radiofrequency, Microwave, Laser, IRE, Ultrasound), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021 3

Tumor Ablation Market by Mode of Treatment (Percutaneous, Surgical, Laparoscopic), Technology (Cryoablation, Radiofrequency, Microwave, Laser, IRE, Ultrasound), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021 4

Tumor Ablation Market by Mode of Treatment (Percutaneous, Surgical, Laparoscopic), Technology (Cryoablation, Radiofrequency, Microwave, Laser, IRE, Ultrasound), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021 5

Tumor Ablation Market by Mode of Treatment (Percutaneous, Surgical, Laparoscopic), Technology (Cryoablation, Radiofrequency, Microwave, Laser, IRE, Ultrasound), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021 6

Tumor Ablation Market by Mode of Treatment (Percutaneous, Surgical, Laparoscopic), Technology (Cryoablation, Radiofrequency, Microwave, Laser, IRE, Ultrasound), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021 7

Tumor Ablation Market by Mode of Treatment (Percutaneous, Surgical, Laparoscopic), Technology (Cryoablation, Radiofrequency, Microwave, Laser, IRE, Ultrasound), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021 8

1 Global Tumor Ablation Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Tumor Ablation Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Tumor Ablation Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Tumor Ablation Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Tumor Ablation Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Tumor Ablation Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Tumor Ablation Market – By Treatment (Market Size – & million/billion)
8.1 Surgical Ablation
8.2 Laparoscopic Ablation
8.3 Percutaneous Ablation

9 Global Tumor Ablation Market – By Technology
9.1 Radiofrequency Ablation
9.2 Microwave Ablation
9.3 Cryoablation
9.4 Other Technologies

10 Global Tumor Ablation Market – By Application
10.1 Liver Cancer
10.2 Lung Cancer
10.3 Kidney Cancer
10.4 Bone Metastasis
10.5 Other

11 Global Tumor Ablation Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Tumor Ablation Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Tumor Ablation Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 AngioDynamics Inc.
13.3 INTIO Inc.
13.4 NeuWave Medical, Inc.
13.5 Medtronic PLC
13.6 Galil Medical, Inc.
13.7 BVM Medical Limited
13.8 SonaCare Medical, LLC
13.9 Misonix, Inc.
13.10 Boston Scientific Corporation
13.11 COMSOL Inc.
13.12 Company 11 & more

14 Global Tumor Ablation Market – Appendix
14.1 Sources
14.2 Abbreviations